KemPharm Inc. [NASDAQ: KMPH] closed the trading session at $10.30 on 03/10/21. The day’s price range saw the stock hit a low of $9.00, while the highest price level was $10.88. The company report on March 9, 2021 that KemPharm to Report Fourth Quarter and Full Year 2020 Financial Results.
Conference Call and Live Audio Webcast with Slide Presentation Scheduled for Thursday, March 11, 2021, 4:30 p.m. ET.
KemPharm, Inc. (NASDAQ: KMPH), a specialty pharmaceutical company focused on the discovery and development of proprietary prodrugs, announced that the Company will host a conference call and live audio webcast on Thursday, March 11, 2021, at 4:30 p.m. ET, to discuss its corporate and financial results for the fourth quarter and full year 2020.
The stocks have a year to date performance of -8.04 percent and weekly performance of -23.53 percent. The stock has been moved at -12.83 percent over the last six months. The stock has performed 9.11 percent around the most recent 30 days and changed -28.47 percent over the most recent 3-months.
If compared to the average trading volume of 3.32M shares, KMPH reached to a volume of 6176420 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about KemPharm Inc. [KMPH]:
H.C. Wainwright have made an estimate for KemPharm Inc. shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on March 04, 2021. While these analysts kept the previous recommendation, ROTH Capital raised their target price to Buy. The new note on the price target was released on January 25, 2021, representing the official price target for KemPharm Inc. stock.
The Average True Range (ATR) for KemPharm Inc. is set at 1.83, with the Price to Sales ratio for KMPH stock in the period of the last 12 months amounting to 15.12.
KMPH stock trade performance evaluation
KemPharm Inc. [KMPH] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -23.53. With this latest performance, KMPH shares gained by 9.11% in over the last four-week period, additionally sinking by -12.83% over the last 6 months – not to mention a rise of 116.75% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for KMPH stock in for the last two-week period is set at 53.04, with the RSI for the last a single of trading hit 53.35, and the three-weeks RSI is set at 52.25 for KemPharm Inc. [KMPH]. The present Moving Average for the last 50 days of trading for this stock 8.67, while it was recorded at 9.66 for the last single week of trading, and 9.02 for the last 200 days.
KemPharm Inc. [KMPH]: An insightful look at the core fundamentals
Operating Margin for any stock indicates how profitable investing would be, and KemPharm Inc. [KMPH] shares currently have an operating margin of -158.40 and a Gross Margin at +74.69. KemPharm Inc.’s Net Margin is presently recorded at -191.00.
Return on Total Capital for KMPH is now -194.07, given the latest momentum, and Return on Invested Capital for the company is -290.36. Additionally, KMPH Total Debt to Total Capital is recorded at 1,459.68, with Total Debt to Total Assets ending up at 760.75.
Reflecting on the efficiency of the workforce at the company, KemPharm Inc. [KMPH] managed to generate an average of -$1,114,636 per employee. Receivables Turnover for the company is 12.81 with a Total Asset Turnover recorded at a value of 0.69.KemPharm Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.10 and a Current Ratio set at 0.10.
Earnings per share (EPS) analysis for KemPharm Inc. [KMPH] stock
With the latest financial reports released by the company, KemPharm Inc. posted -0.16/share EPS, while the average EPS was predicted by analysts to be reported at -1.36/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 88.20%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for KMPH.
KemPharm Inc. [KMPH]: Insider Ownership positions
Positions in KemPharm Inc. stocks held by institutional investors increased at the end of March and at the time of the March reporting period, where 1 institutional holders increased their position in KemPharm Inc. [NASDAQ:KMPH] by around 1,250 shares. Additionally, 1 investors decreased positions by around 2,750 shares, while 0 investors held positions by with 2,750 shares. The mentioned changes placed institutional holdings at 1,250 shares, according to the latest SEC report filing. KMPH stock had 1 new institutional investments in for a total of 1,250 shares, while 1 institutional investors sold positions of 2,750 shares during the same period.